William Grossman - Net Worth and Insider Trading
William Grossman Net Worth
The estimated net worth of William Grossman is at least $322,243 dollars as of 2024-04-28. William Grossman is the Chief Medical Officer of Arcus Biosciences Inc and owns about 20,723 shares of Arcus Biosciences Inc (RCUS) stock worth over $322,243. Details can be seen in William Grossman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that William Grossman has not made any transactions after 2021-06-17 and currently still holds the listed stock(s).
Transaction Summary of William Grossman
William Grossman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William Grossman owns 2 companies in total, including Arcus Biosciences Inc (RCUS) , and Bellicum Pharmaceuticals Inc (BLCM) .
Click here to see the complete history of William Grossman’s form 4 insider trades.
Insider Ownership Summary of William Grossman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RCUS | Arcus Biosciences Inc | 2021-06-17 | Chief Medical Officer |
| BLCM | Bellicum Pharmaceuticals Inc | 2018-02-05 | Sr. VP & Chief Medical Officer |
William Grossman Latest Holdings Summary
William Grossman currently owns a total of 1 stock. William Grossman owns 20,723 shares of Arcus Biosciences Inc (RCUS) as of June 17, 2021, with a value of $322,243.
Latest Holdings of William Grossman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RCUS | Arcus Biosciences Inc | 2021-06-17 | 20,723 | 15.55 | 322,243 |
Holding Weightings of William Grossman
William Grossman Form 4 Trading Tracker
According to the SEC Form 4 filings, William Grossman has made a total of 5 transactions in Arcus Biosciences Inc (RCUS) over the past 5 years, including 2 buys and 3 sells. The most-recent trade in Arcus Biosciences Inc is the sale of 7,065 shares on June 17, 2021, which brought William Grossman around $168,783.
Insider Trading History of William Grossman
- 1
William Grossman Trading Performance
GuruFocus tracks the stock performance after each of William Grossman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William Grossman is 19.31%. GuruFocus also compares William Grossman's trading performance to market benchmark return within the same time period. The performance of stocks bought by William Grossman within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William Grossman's insider trading performs compared to the benchmark.
Performance of William Grossman
Average Return
101.66%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.22 | 19.31 | 93.04 | 101.66 | 58.78 | 24.79 |
| Relative Return to S&P 500(%) | 4.51 | 13.98 | 88.29 | 75.7 | 41.44 | 15.57 |
William Grossman Ownership Network
Ownership Network List of William Grossman
Ownership Network Relation of William Grossman
William Grossman Owned Company Details
What does Arcus Biosciences Inc do?
Who are the key executives at Arcus Biosciences Inc?
William Grossman is the Chief Medical Officer of Arcus Biosciences Inc. Other key executives at Arcus Biosciences Inc include See Remarks Jennifer Jarrett , director & 10 percent owner & President Juan C. Jaen , and 10 percent owner Gilead Sciences Inc .
Arcus Biosciences Inc (RCUS) Insider Trades Summary
Over the past 18 months, William Grossman made no insider transaction in Arcus Biosciences Inc (RCUS). Other recent insider transactions involving Arcus Biosciences Inc (RCUS) include a net sale of 223,626 shares made by Jennifer Jarrett , a net sale of 38,443 shares made by Juan C. Jaen , and a net sale of 8,506 shares made by Goeltz Ii Robert C. .
In summary, during the past 3 months, insiders sold 110,657 shares of Arcus Biosciences Inc (RCUS) in total and bought 15,238,095 shares, with a net purchase of 15,127,438 shares. During the past 18 months, 286,423 shares of Arcus Biosciences Inc (RCUS) were sold and 16,248,095 shares were bought by its insiders, resulting in a net purchase of 15,961,672 shares.
Arcus Biosciences Inc (RCUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arcus Biosciences Inc Insider Transactions
William Grossman Mailing Address
Above is the net worth, insider trading, and ownership report for William Grossman. You might contact William Grossman via mailing address: C/o Bellicum Pharmaceuticals, Inc., 2130 W. Holcombe Blvd., Ste. 800, Houston Tx 77030.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
